The latest oncology news listed by date, covering all clinical focus areas, tumour types and more
Two-year data from the ZUMA-7 trial primary analysis show that the CAR T-cell therapy axicabtagene…
Patients receiving the anti-CD38 monoclonal antibody isatuximab in addition to the standard three- component induction…
An interim analysis of the TRANSFORM trial comparing CAR T-cell therapy lisocabtagene maraleucel (liso-cel) to…
The Phase II ZUMA-12 trial expands on the ZUMA-1 findings by evaluating the use of axicabtagene ciloleucel…
Follow-up data from the Phase II ZUMA-5 trial showed a long-term survival benefit with axicabtagene ciloleucel (axi-cel)…
A phase I/II trial for the experimental drug mosunetuzumab met its primary endpoint, leading to…
A combination of five existing drugs keeps cancer at bay for longer in patients with…
Clinician scientists and scientists from the National Cancer Centre Singapore (NCCS) and A*STAR’s Genome Institute…
The first results from the largest screening study yet conducted in the United States of…
An experimental drug enhanced the benefit of an immunotherapy to fight pancreatic cancer in mice…